Exchange Traded Concepts’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,693
Closed -$798K 1384
2024
Q2
$798K Buy
9,693
+459
+5% +$33.7K 0.02% 516
2024
Q1
$613K Sell
9,234
-14,422
-61% -$890K 0.02% 624
2023
Q4
$1.34M Buy
23,656
+187
+0.8% +$9.8K 0.04% 335
2023
Q3
$1.28M Buy
+23,469
New +$1.39M 0.04% 317
2022
Q1
Sell
-22,926
Closed -$1.15M 1289
2021
Q4
$1.15M Buy
22,926
+400
+2% +$20.7K 0.02% 327
2021
Q3
$1.2M Buy
+22,526
New +$1.27M 0.03% 296

Other funds holding LMAT

Exchange Traded Concepts's LMAT Position: Q3 2024 in Review

Exchange Traded Concepts sold out of LeMaitre Vascular (LMAT) in Q3 2024, closing a stake of 9,693 shares — an estimated $798K sold.

Exchange Traded Concepts first reported a position in LMAT in Q3 2021 and held it in 6 quarters. The position peaked at $1.34M in Q4 2023. 291 funds tracked by Wall St. Rank hold LMAT as of Q3 2024.

  • Exchange Traded Concepts reported no remaining LeMaitre Vascular position as of Q3 2024 after selling out during the quarter.
  • Exchange Traded Concepts sold 9,693 LeMaitre Vascular shares in Q3 2024, an estimated $798K.
  • Exchange Traded Concepts first reported a position in LeMaitre Vascular in Q3 2021 and held it in 6 quarters.
  • Exchange Traded Concepts's LeMaitre Vascular position peaked at $1.34M in Q4 2023.
  • 291 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2024.

Based on Exchange Traded Concepts's 13F filing for Q3 2024, filed 10 Oct 2024.